Wellspect Healthcare

What Wellspect Healthcare does

Wellspect Healthcare is a Sweden-based MedTech company specializing in continence care, operating as a wholly-owned subsidiary of Dentsply Sirona. Founded in Sweden (firmographic year 1948, with company-history sources citing 1983 as the Wellspect-specific founding date) and headquartered in Mölndal, the company develops and manufactures medical devices for bladder and bowel management under three principal brands: LoFric (hydrophilic intermittent catheters), Navina (transanal irrigation systems), and Surity (external catheters for urinary incontinence). The company's core proprietary technology is Urotonic Surface Technology, a hydrophilic coating on LoFric catheters that maintains smoothness during insertion and withdrawal, with clinical evidence demonstrating 0% trauma in long-term follow-up. Recent product introductions include Pro eyelets technology (LoFric Elle Pro and Origo Pro) for complete bladder emptying without repositioning, and the Surity external catheter line targeting the estimated 13 million Americans with severe urinary incontinence.

The company operates a hybrid go-to-market model combining direct enterprise sales to hospitals and rehabilitation centers, wholly-owned regional subsidiaries across 14+ European and US markets, a global distributor network covering 40+ countries, and direct-to-consumer e-commerce via surity.care and local market websites. Products are prescription medical devices typically covered by insurance, with pricing not publicly disclosed. The customer base spans two primary segments: individuals managing chronic urinary or bowel dysfunction (spinal cord injury, multiple sclerosis, spina bifida, Parkinson's, diabetes, post-surgical conditions) and the healthcare professionals who prescribe and train on these products (urologists, continence nurses, physiotherapists).

Wellspect maintains an extensive regulatory and quality footprint including ISO 13485:2016, MDR 2017/745, FDA 21 CFR 820, MDSAP, ISO 14001:2015, plus country-specific clearances for Canada, Japan, Australia, South Korea, and China. The company holds Nordic Swan Ecolabel certification for selected products. Recent strategic activity centers on portfolio expansion in the external catheter category (Surity Male and Female launches in 2026), US direct-to-consumer channel buildout, and participation in the Swedish National Climate Initiative committing to net-zero emissions by 2045. Total revenue is not publicly disclosed; based on headcount of 1,001-5,000 and comparable MedTech revenue-per-employee benchmarks, revenue is estimated in the $250M-$500M range with low confidence.

Name

Wellspect Healthcare

Legal name

Wellspect AB

Website

https://wellspect.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Wellspect Healthcare is a Sweden-based MedTech subsidiary of Dentsply Sirona specializing in continence care. It develops hydrophilic intermittent catheters (LoFric), transanal irrigation systems (Navina), and external catheters (Surity) for patients with bladder and bowel dysfunction across 40+ countries.

Ownership category

akta.pro rank

Product category

Continence Care Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement) (HLAHALAI)

akta.pro secondary industries

Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors) (HLAHALAH), Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)

Keywords

• Hydrophilic intermittent catheters
• Transanal irrigation systems
• External urinary catheters
• Continence care devices
• Bowel management products

Headquarters

HQ city

Mölndal

HQ country

Sweden

HQ region

Europe

Offices14 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Continence Care Medical Devices: Direct sales of proprietary medical devices for bladder and bowel management including intermittent catheters (LoFric family), transanal irrigation systems (Navina), and external catheters (Surity). Products are single-use disposable medical devices sold to healthcare providers and directly to patients.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Wellspect Healthcare designs, manufactures, and sells proprietary continence care medical devices for bladder and bowel management. Its core product families are the LoFric line of hydrophilic intermittent catheters featuring Urotonic Surface Technology, the Navina transanal irrigation systems for bowel care, and the Surity external catheters for non-invasive urinary incontinence management. Products are single-use disposable medical devices sold to healthcare institutions, clinicians, and directly to patients across more than 40 countries.

Product overview

Wellspect Healthcare is a global MedTech company specializing in continence care with over 40 years of experience. The company offers two main product portfolios: bladder management products under the LoFric® brand (including LoFric, LoFric Primo, LoFric Origo/Origo Pro, LoFric Elle/Elle Pro, LoFric Sense, LoFric Hydro-Kit, LoFric Dila-Cath, and LoFric Insti-Cath - all featuring proprietary Urotonic™ Surface Technology for smooth catheterization) and external catheter solutions under the Surity™ brand for both men and women with urinary incontinence. All products are designed for intermittent catheterization except the Surity external catheters which are non-invasive options.

Differentiator

Problem solved

Functional benefit

Brands

• LoFric: Brand of hydrophilic intermittent catheters for bladder management, including LoFric, LoFric Primo, LoFric Origo, LoFric Elle, LoFric Sense, LoFric Hydro-Kit, LoFric Dila-Cath, and LoFric Insti-Cath products.
• Navina
• Surity

Products and services

• LoFric The first hydrophilic catheter developed for intermittent catheterization, requiring clean water to activate the Urotonic Surface Technology coating. Available in Nelaton and Tiemann/Coudé tips, lengths from 15 to 40 cm, and CH 06 to CH 22 sizes. Used by individuals performing self-catheterization for bladder emptying.
• LoFric Primo Hydrophilic intermittent catheter packaged with its own salt solution for activation. Features an integrated insertion guide for non-touch technique and folds to pocket size for discreet carrying. Available in 15-40 cm lengths and CH 06-CH 18 sizes.
• LoFric Origo User-friendly hydrophilic intermittent catheter that folds to pocket size. Available with insertion grip or extendable protective sleeve. Options include Nelaton, Flexible, and Tiemann/Coudé tips in 30-40 cm lengths. Designed for discreet self-catheterization.
• LoFric Origo Pro Hydrophilic intermittent catheter for men featuring multiple smooth Pro eyelets (12) designed to allow complete bladder emptying without repositioning the catheter. Foldable to pocket size with flexible tip and extendable protective sleeve for hygienic non-touch insertion.
• LoFric Elle Hydrophilic intermittent catheter designed for women featuring an ergonomic L-shaped handle to support visibility when using a mirror and an upright sitting position during catheterization. Slim, discreet design with 10 cm length and CH 10-CH 14 sizes.
• LoFric Elle Pro Hydrophilic intermittent catheter designed for women with twelve smooth Pro eyelets for complete bladder emptying in one free flow without repositioning. Features the L-shaped handle for visibility and positioning, slim discreet design, 10 cm length, and CH 10-CH 14 sizes.
• LoFric Sense Hydrophilic intermittent catheter tailor-made for women with an ergonomic grip for better control and non-touch technique. The package doubles as a hygienic disposal pouch. Discreet non-medical design fits in a pocket or purse. CH 08-CH 14 sizes with 15 cm length.
• LoFric Hydro-Kit All-in-one hydrophilic catheter kit with integrated 1000 ml collection bag with printed scale. Ready to use with salt solution activation. Features a textured Insertion Grip for non-touch technique. Available in 20-40 cm lengths and CH 08-CH 18 sizes.
• LoFric Dila-Cath Hydrophilic catheter designed for intermittent dilatation of the urethra without drainage eyelets. Requires water activation of Urotonic Surface Technology. Available with Nelaton tip, 40 cm length, and CH 16-CH 18 sizes.
• LoFric Insti-Cath Hydrophilic catheter for bladder instillation solutions with Luer-lock connector to minimize spillage risk. Designed for patients with bladder pain syndrome and non-muscle-invasive bladder cancer. Available in Nelaton and Tiemann/Coudé tips, 20-40 cm lengths, CH 08-CH 14 sizes.
• Surity Female External Catheter Non-invasive external catheter specifically designed for women with severe urinary incontinence. Engineered to prevent leakage, protect skin, and support extended overnight use. Available for direct home purchase through www.surity.care.
• Surity Male External Catheter Non-invasive external catheter for men with severe urinary incontinence. Features a see-through design for easy placement, slim profile to reduce bulk, and soft non-woven backing material for skin-friendly wear up to 24 hours. Available for home purchase through www.surity.care.

Quantifiable outcome

• LoFric catheters demonstrated 0% trauma identified during 5-9 year follow-up
• +2 more outcomes

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Swedish Healthcare and Life Science National Climate InitiativecoreStrategic or Co-development Partner · 3 February 2026Wellspect HealthCare joined a broad public-private National Climate Initiative for the Swedish healthcare and life science sector aimed at achieving net-zero emissions across the entire healthcare value chain by 2045. The initiative involves over 20 organizations including pharmaceutical companies, pharmacy chains, regional healthcare authorities, and industry associations committing to time-bound transition plans aligned with the Paris Agreement. Wellspect states the partnership aligns with its own long-term net-zero ambition while maintaining focus on patients with chronic continence conditions.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Cure Medical: US-based intermittent catheter manufacturer competing primarily in the North American hydrophilic catheter market with a mission-driven positioning, representing a more focused but smaller-scale competitor to Wellspect's LoFric line.
• Welland Medical: UK-based specialist in ostomy and continence products including catheters, with overlapping customer segments (continence nurses, urology departments) and a comparable niche focus to Wellspect, though at smaller scale.

Direct peers

• Convatec: UK-listed MedTech company with a continence care business (including GentleCath hydrophilic catheters) and ostomy/wound care portfolio, directly competing with Wellspect across intermittent catheterization and bowel management.
• Hollister Incorporated: US-based privately held manufacturer of ostomy, continence, and critical care products. Hollister's VaPro and Apogee intermittent catheter lines compete head-to-head with LoFric in the US and Europe, serving the same patient and clinician segments.
• Coloplast: Danish global MedTech leader and the dominant competitor in ostomy and continence care, with a SpeediCath hydrophilic catheter portfolio that directly competes with Wellspect's LoFric family across the same patient populations and channels.
• Teleflex: US-listed MedTech company offering a broad urology portfolio including intermittent catheters and urinary management products, directly competing with Wellspect's LoFric line in hospital and home-care channels.

Others

• Dentsply Sirona: Public parent company of Wellspect, primarily focused on dental equipment and consumables. Listed as a peer for ecosystem context given shared corporate infrastructure, global distribution synergies, and capital allocation dynamics affecting Wellspect.

Broad incumbents

• Medtronic: Global diversified medical device leader with products in urology, pelvic health, and bladder/bowel dysfunction that overlap thematically with Wellspect's continence care focus, though continence is a small slice of Medtronic's broader portfolio.
• Becton Dickinson (BD): Global medical technology giant with a urology and home-care portfolio (including hydrophilic catheters via acquired Bard assets) that competes with Wellspect in catheterization and incontinence management as part of a much broader medtech portfolio.
• B. Braun: Large German medical device and pharmaceutical company with a urology and continence care portfolio (Actreen, Urimed) that overlaps with Wellspect's intermittent catheter and urological consumables offering, alongside much broader hospital products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/WellspectHC
• Facebookfacebook.com/wellspect
• LinkedInlinkedin.com/company/wellspect-healthcare
• Instagraminstagram.com/wellspect

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellspect Healthcare